First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1612-9067
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50) ; day:19 ; month:11 ; year:2022 ; pages:1-11
Esophagus ; (19.11.2022), 1-11
- Creator
-
Kato, Ken
Doki, Yuichiro
Ogata, Takashi
Motoyama, Satoru
Kawakami, Hisato
Ueno, Masaki
Kojima, Takashi
Shirakawa, Yasuhiro
Okada, Morihito
Ishihara, Ryu
Kubota, Yutaro
Amaya-Chanaga, Carlos
Chen, Tian
Matsumura, Yasuhiro
Kitagawa, Yuko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10388-022-00970-1
- URN
-
urn:nbn:de:101:1-2023020121023692042525
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kato, Ken
- Doki, Yuichiro
- Ogata, Takashi
- Motoyama, Satoru
- Kawakami, Hisato
- Ueno, Masaki
- Kojima, Takashi
- Shirakawa, Yasuhiro
- Okada, Morihito
- Ishihara, Ryu
- Kubota, Yutaro
- Amaya-Chanaga, Carlos
- Chen, Tian
- Matsumura, Yasuhiro
- Kitagawa, Yuko
- SpringerLink (Online service)
Other Objects (12)
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study)
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study)
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study)